A federal appeals court in the United States has ruled that Brianne Dressen cannot sue AstraZeneca for breach of contract over the injuries she suffered due to the pharmaceutical giant’s COVID-19 shot clinical trial. The Tenth Circuit Court of Appeals reversed a lower court and held that the Public Readiness and Emergency Preparedness (PREP) Act shields AstraZeneca, even though Dressen sued over a broken promise.1 Brianne Dressen is the founder of React19, an organization advocating for people injured by COVID shots.
Volunteer Trial Participant Says Shot Left Her With Debilitating Injuries
Dressen was working as a preschool teacher in Utah when she received AstraZeneca’s experimental COVID shot in November 2020.2 The clinical trial was conducted for the drug company by Velocity Clinical Research.3 She experienced a severe systemic and neurological reaction and was left with lifelong debilitating injuries, with doctors at the National Institutes of Health subsequently diagnosing her with immune and brain dysfunction caused by the shot.4
Dressen first filed a lawsuit against the pharmaceutical giant in May 2024.5
Company’s Consent Form Promised to Pay for Research Injuries
Before the COVID shot trial, Dressen signed an informed consent form, which stated that AstraZeneca, “will pay the costs of medical treatment for research injuries,” as long as the costs were, “reasonable” and she did not cause the injury herself.6 The AstraZeneca form also warned that a federal order “may limit your right to sue” if a participant was hurt in a COVID shot clinical trial, but did not explain further exactly why or what that would mean for a volunteer participant who was injured by the company’s experimental vaccine during the trial.7
When AstraZeneca refused to pay Dressen for her injuries, she sued them for breach of contract. According to court documents, the company first offered her only $590.20 and later made a final offer of $1,243.8
Lower Court Called It a Broken Promise
AstraZeneca asked the federal court in Utah to dismiss the case under the Public Readiness and Emergency Preparedness (PREP) Act.9 The 2005 law passed by Congress allows the Secretary of Health and Human Services to declare a public health emergency and recommend “countermeasures” to address the emergency, such as the use of experimental drugs and vaccines like the COVID shots. Once that happens, the law provides:
[A] covered person shall be immune from suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a covered countermeasure if a declaration under subsection (b) has been issued with respect to such countermeasure.10
On Nov. 4, 2024, U.S. District Judge Robert J. Shelby refused to dismiss Dressen’s lawsuit against AstraZeneca. He wrote:
The basis of Dressen’s claim is a broken promise, not a countermeasure.11
Tenth Circuit Appeals Court Reverses Ruling in Favor of Dressen’s Case
AstraZeneca appealed, and on July 23, 2026, a three-judge Tenth Circuit panel sided with the pharmaceutical company giant. Judge Harris Hartz wrote for the panel that the PREP Act entirely protects AstraZeneca from the lawsuit.12 The court rejected the argument that a contract case is different from a vaccine injury case. It wrote:
A suit for breach of contract is as much a ‘claim’ as a suit under tort law.13
The court also compared the PREP Act to the Protection of Lawful Commerce in Arms Act, which protects gun makers but carves out contract claims. The court wrote:
Congress knew how to enact such an exemption and chose not to in the PREP Act.14
According to the court, the PREP Act has one exception, for willful misconduct. A person who suffers death or serious physical injury caused by willful misconduct can bring a special federal claim.15
The Tenth Circuit sent the case back to the district court to decide whether AstraZeneca gave up its immunity in the consent form.16
The PREP Act Points Injured People to a Federal Countermeasures Injury Compensation Program (CICP)
The two decade old PREP Act prohibits most lawsuits against the makers of covered biologicals and countermeasures used during a government declared public health emergency. To offer compensation to Americans injured by public health emergency “countermeasures” implemented under the PREP Act, a Countermeasures Injury Compensation Program (CICP) was created by Congress, which is run by the Health Resources and Services Administration.17
The CICP is supposed to pay for covered serious injuries and deaths caused by countermeasures, including unreimbursed medical expenses and lost income. Claims for COVID shot injuries must be filed in the CICP within one year of getting the shot.18
However, the program’s own numbers show how little the CICP pays out to those injured and killed by covered COVID vaccines. As of Oct. 1, 2026, 14,250 CICP claims have been filed due to COVID countermeasures, including 11,198 claims for injuries from the COVID shots.19 Of the 8,369 claims decided, 8,249 were denied. Therefore, only a mere 66 claims out of 8,359 claims were compensated, which is less than half of one percent of the claims filed.20
The COVID vaccine injured were informed by HRSA that denials of their claims were blamed on missed deadlines, failure to submit the proper paperwork, and lack of proof of causation. HRSA denied 2,730 claims because the injured claimant missed the one-year filing deadline and 3,585 because the requested medical records were allegedly not submitted. Another 1,670 were denied because the standard of proof was not met or the injury was not a CICP covered injury.21
In addition, when the CICP fund does pay out, the payouts are minimal. The 66 COVID shot payments in HRSA’s compensation table add up to about $7.99 million, and only one of them, $5.94 million for a blood clotting disorder called thrombosis with thrombocytopenia syndrome (TTS), makes up most of that total. Sadly, 50 of the 66 payments were under $10,000.22
The 2009 H1N1 flu shot during the H1N1 “swine flu” epidemic shows the same pattern in terms of failure to compensate claims filed in the CICP. HRSA’s CICP compensation table lists only 29 compensated H1N1 shot claims totaling about $5.76 million.23 Across every countermeasure since the program began in 2010, HRSA has received 14,879 claims and has only compensated 96 of them.24
AstraZeneca’s Lawyers Call It a Precedential Victory
Arnold & Porter, the law firm that represented AstraZeneca, called the decision a precedential victory. The firm said the opinion was unanimous and that the case went back solely on whether AstraZeneca waived its immunity by contract.25
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
Click here to view References:1 Dressen v. AstraZeneca AB, No. 24-4114. U.S. Court of Appeals for the Tenth Circuit. July 23, 2026.
2 Stieber Z. Judge Denies AstraZeneca’s Motion to Dismiss in Vaccine Injury Case. The Epoch Times Nov. 7, 2024.
3 Dressen v. AstraZeneca AB, No. 24-4114. U.S. Court of Appeals for the Tenth Circuit. July 23, 2026.
4 Stieber Z. Judge Denies AstraZeneca’s Motion to Dismiss in Vaccine Injury Case. The Epoch Times Nov. 7, 2024.
5 Hendler C. AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects. The Vaccine Reaction May 20, 2024.
6 Dressen v. AstraZeneca AB, No. 24-4114. U.S. Court of Appeals for the Tenth Circuit. July 23, 2026.
7 Ibid.
8 Stieber Z. Judge Denies AstraZeneca’s Motion to Dismiss in Vaccine Injury Case. The Epoch Times Nov. 7, 2024.
9 Administration for Strategic Preparedness and Response. Public Readiness and Emergency Preparedness (PREP) Act.
10 42 U.S.C. § 247d-6d. Targeted liability protections for pandemic and epidemic products and security countermeasures. Cornell Law School Legal Information Institute.
11 Stieber Z. Judge Denies AstraZeneca’s Motion to Dismiss in Vaccine Injury Case. The Epoch Times Nov. 7, 2024.
12 Dressen v. AstraZeneca AB, No. 24-4114. U.S. Court of Appeals for the Tenth Circuit. July 23, 2026.
13 Ibid.
14 Ibid.
15 Ibid.
16 Ibid.
17 Ibid.
18 Countermeasures Injury Compensation Program. Health Resources and Services Administration May 2026.
19 CICP Data. Health Resources and Services Administration Oct. 1, 2026.
20 Ibid.
21 Ibid.
22 Table 4. CICP Claims Compensated (Fiscal Years 2010 – 2026). Health Resources and Services Administration Oct. 1, 2026.
23 Ibid.
24 CICP Data. Health Resources and Services Administration Oct. 1, 2026.
25 Arnold & Porter Secures Precedential Tenth Circuit Victory for AstraZeneca in PREP Act Immunity Case. Arnold & Porter Aug. 18, 2026.












